Ashique Ali Arain, Umair Ali Soomro, Shumaila Shaikh, Shagufta Memon, Kashif Rasheed Shaikh, Saima Hingoro

Frequency of Multidrug-Resistant Tuberculosis in Patients Visiting the Center of Tuberculosis at District Mirpur Khas, Sindh

Ashique Ali Arain, Umair Ali Soomro, Shumaila Shaikh, Shagufta Memon, Kashif Rasheed Shaikh, Saima Hingoro



1220



ABSTRACT

Background: Tuberculosis is a mycobacterial infection caused by mycobacterium tuberculous bacillus. Antituberculous drugs are drugs used to treat tuberculosis which include first line anti-tuberculosis drugs used to treat tuberculosis initially when the infection is non-resistant these include Isoniazid, Refampicin, Pyrazinamide, Ethambutol. Second line anti-tuberculosis drugs which are used to treat resistant tuberculosis or whenfirst line drugs are contraindicated these include Ethionamide, Capreomyin, ciprofloxacin etc. Multidrug-resitant tuberculosis is tuberculosis not responding to 2 first line antituberulosis drugs.

Aims: To determine the frequency of multidrug-resistant tuberculosis cases and to determine the difference between the two genders.

Study Design: Cross sectional study.

Place and Duration of Study: Tuberculosis Center Mirpur Khas from 1st February 2015 to 28th February 2017.

Methodology: Two hundred and six tuberculosis patients were evaluated for multidrug-resistant tuberculosis and non-MDR tuberculosis and information was obtained.

Results: Multidrug-resistant cases were 184 (89.32%) while non-MDR cases were 19 (10.68%) with a non-significant difference between the two genders at p-value 0.675. INH resistance was observed in 4 (1.94%) patients, Resistance against the Rifampicin was seen in 15 (7.28%) patients while other cases were of multi drug resistant tuberculosis.

Conclusion: Multidrug-resistant tuberculosis is highly prevalent in the region and there is non-significant association between MDR-tuberculosis and the sex of the patient.

Keywords: Multidrug-resistant (MDR) tuberculosis, Frequency, Gender



Copyright © Pakistan Journal of Medical & Health Sciences 2024. All rights reserved!